Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg BID, PRN In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea

NCT00649415 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00649415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00649415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg BID, PRN In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2003
Completion date
July 31, 2003
Enrollment
154 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

dysmenorrhea